In 2017, David C. Paul earned $411.71K in total compensation at Globus Medical, primarily from $380.16K salary. Most recently sold 2,053,330 shares in Sep 2018. Currently holds stock worth $29.58M. Has donated $91.10M in stock to charitable causes. Led Globus Medical as CEO for 14 years.
Compensation History
Annual executive compensation data for David C. Paul, including salary, bonuses, and stock awards.
Year
2017
Total Compensation
$411.71K
Salary
$380.16K
Bonus
$0.00
Other
$31.55K
Salary
$380.16KBoard Justification
The compensation philosophy is centered on attracting and retaining talented leaders, with a focus on performance-based compensation that aligns with shareholder returns.
Bonus
$0.00Board Justification
No bonus was paid in 2018.
Other Compensation
$31.55KBoard Justification
Includes participation in group health insurance benefits and other perquisites.
Restricted Stock
Board Justification
No stock was vested in 2018 as the focus is on cash compensation.
Performance Metrics
The performance metrics include achieving corporate objectives, particularly sales revenue, with a target revenue goal of $690 million for 2018.
David C. Paul
Founder and Ex-CEO of Globus Medical
Education
N/A
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
January 1, 1959 - 66 years ago
CEO of Globus Medical for
14 years 7 months (Jan 2003 - Aug 2017)
Previous Experience
Chairman and CEO of Globus Medical, Inc. since its inception in 2003.
Other Globus Medical CEOs
Holdings
Track David C. Paul's stock holdings and portfolio value over time.
Total Stock Sold
$243.46M
$243.46M
7,848,560 GMED shares
What if they kept their stock?
If David C. Paul didn't sell their stock, today they would have:
Extra GMED7,848,560 shares worth $715.00M.
This is 193.68% and $471.54M more than what they got when they sold the stock.
Charitable Transactions
1,000,000 shares
GMED
Recent Charitable Transactions
500,000 shares
GMED
Jan 20, 2015
Charity
500,000 shares
GMED
Jan 20, 2015
Charity
Insider Trading
David C. Paul's recent stock transactions, purchases, and sales filed with the SEC.
$111.19M
GMED at $54.15/share
Sep 24, 2018
Sale
$362.23K
GMED at $52.95/share
Jul 17, 2018
Sale
$42.84M
GMED at $51.80/share
Apr 26, 2018
Sale
$48.05M
GMED at $25.00/share
Mar 18, 2015
Sale
500,000 shares
GMED
Jan 20, 2015
Charity
500,000 shares
GMED
Jan 20, 2015
Charity
$33.92M
GMED at $11.16/share
Aug 8, 2012
Sale
Rivals
Compare David C. Paul with competitor CEOs and industry peers.